ALDX – aldeyra therapeutics, inc. (US:NASDAQ)
Stock Stats
News
5/8
07:08 am
aldx
Low
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease [Yahoo! Finance]
5/8
07:00 am
aldx
Low
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
5/7
12:32 am
aldx
Low
Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
5/6
08:06 am
aldx
Low
Aldeyra Therapeutics, Inc (NASDAQ: ALDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
5/6
08:05 am
aldx
Low
Aldeyra Therapeutics, Inc (NASDAQ: ALDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
5/2/2024
04:03 pm
ALDX
1.7%
MISS
8/3/2023
04:03 pm
ALDX
1.4%
BEAT
5/6
08:06 am
Reiterates
Buy
Buy
HC Wainwright
Low
-0.7%
5/6
08:05 am
Reiterates
Outperform
Outperform
Oppenheimer Holdings Inc.
Low
-0.7%
5/6
07:45 am
Reiterates
Outperform
Outperform
Oppenheimer
Low
0.7%
5/6
07:45 am
Reiterates
Outperform
Outperform
Oppenheimer
Low
0.7%
4/3
09:56 am
Upgrades
Perform
Outperform
Oppenheimer
Low
3.0%
5/2
04:04 pm
aldx
Low
Form 10-Q Aldeyra Therapeutics, For: Mar 31
4/25
07:03 am
aldx
Low
Form 8-K Aldeyra Therapeutics, For: Apr 25
4/25
06:05 am
aldx
Medium
Form EFFECT Aldeyra Therapeutics,
4/22
04:19 pm
aldx
Low
Form ARS Aldeyra Therapeutics, For: Dec 31
4/22
04:14 pm
aldx
Low
Form DEFA14A Aldeyra Therapeutics,
Show more
Top News Gainers
4/14 Aldeyra Announces Positive Top-Line Phase 1 Clinical Trial Results and Clinical Development Plans for ADX-629 27.8%
3/24 Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infection 22.9%
9/9 Form 4 Aldeyra Therapeutics, For: Sep 05 Filed by: McMullin David 13.9%
4/27 Form DEF 14A Aldeyra Therapeutics, For: Jun 09 13.1%
10/14 Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 9.9%
3/26 Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.0%
10/2 Form 4 Aldeyra Therapeutics, For: Sep 30 Filed by: Brady Todd C 8.1%
12/18 Form 4 Aldeyra Therapeutics, For: Dec 16 Filed by: Brady Todd C 5.9%
11/1 Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third-Quarter 2019 Financial Results and Corporate Update 5.0%
1/15 Form 3 Aldeyra Therapeutics, For: Jan 13 Filed by: Miller-Rich Nancy 4.2%
Top News Decliners
12/3 Aldeyra Therapeutics Announces Positive Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease -40.4%
3/24 Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. -17.8%
3/17 Form 4 Aldeyra Therapeutics, For: Mar 16 Filed by: DOUGLAS RICHARD -15.3%
3/6 Form 4/A Aldeyra Therapeutics, For: Mar 02 Filed by: Reed Joshua -15.3%
3/12 Aldeyra Therapeutics Reports Full-Year 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones -14.2%
8/14 Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.5%
2/24 Aldeyra Therapeutics to Provide Update on Late-Stage Clinical Development Pipeline at 2020 Research & Development Day -7.3%
2/25 Form SC 13G Aldeyra Therapeutics, Filed by: Prosight Management, LP -7.0%
10/31 Form 8-K Aldeyra Therapeutics, For: Oct 31 -6.7%
4/30 Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide First-Quarter 2020 Financial Results and Corporate Update -6.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3